Research Data: Glucagon Secretion Mechanism and Key Triggers
Title: Research Data: Glucagon Secretion Mechanism and Key Triggers Abstract: Glucagon secretion, primarily triggered by hypoglycemia and amino acids, is regulated via paracrine insulin signaling and intra-islet somatostatin. Key mechanisms involve K_ATP channel closure and cAMP-PKA pathways. In the peptide industry, GLP-1 receptor agonists dominate market trends, while glucagon-based dual/triple agonists (e.g., GLP-1/glucagon) show superior metabolic benefits. Brand comparisons reveal Novo Nordisk’s patent leadership vs. emerging Chinese manufacturers. Technical trade-offs include stability vs. receptor selectivity. Product certifications (FDA, NMPA, GMP) are critical for quality assurance. Selection criteria prioritize purity (>98%), bioassay validation, and cold-chain logistics. Industry outlook: CAGR 8.5% (2024–2030), driven by obesity and diabetes therapeutics.